Ajanta Pharma Ltd.
Industry Group: Pharmaceuticals
Country/Region: India
Identifier: BOM:532331
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a presence while generating the vast majority of its revenue in India. The company aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, creams, injectables, capsules, liquids, and lotion. The company's manufacturing plants are located in India.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 476 out of 851
Universe
Global Universe 10888 out of 15100
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the non-India based rated subjects, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Livzon Pharmaceutical Group, Inc. |
24.5
Medium
|
177 out of 851 |
Ajanta Pharma Ltd. |
30.7
High
|
476 out of 851 |
PT Kalbe Farma Tbk |
33.3
High
|
589 out of 851 |
Taisho Pharmaceutical Holdings Co., Ltd. |
33.4
High
|
596 out of 851 |
Kangmei Pharmaceutical Co., Ltd. |
41.5
Severe
|
835 out of 851 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Ajanta Pharma Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Ajanta Pharma Ltd.'s Management of ESG Material Risk is Weak